Anika Therapeutics (NASDAQ: ANIK)
Anika Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Anika Therapeutics Company Info
Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.
News & Analysis
Anika Therapeutics Beats Revenue and Earnings Estimates
A recent acquisition and a new product launch held back earnings, but should be beneficial over the long term.
Why Anika Therapeutics Stock Crushed It Today
Better-than-expected Q2 earnings results spurred investors' interest in the small biotech.
Anika Therapeutics Blows Past Q2 Earnings Estimates
Wall Street wasn't nearly as optimistic as it should have been about the biotech's second quarter.
Why Pivotal Software, Anika Therapeutics, and Oracle Slumped Today
Find out which of these companies took the biggest hit.
Why Anika Therapeutics, Inc. Stock Is Sinking
Shares dropped after the company reported data from a late-stage trial. Here's what investors need to know.
3 Biotech Stocks to Buy in May
On the hunt for a biotech bargain? Our contributors think you should give these three stocks a closer look.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.